Legal Opinion
Xu v. FibroGen, Inc.
District Court, N.D. California
Decided August 30, 2021No. 3:21-cv-02623Unknown
1Opinion
1 2 3 4 UNITED STATES DISTRICT COURT 5 NORTHERN DISTRICT OF CALIFORNIA 6 7 PEIFA XU, Case No. 21-cv-02623-EMC 8 Plaintiff, ORDER GRANTING MOTIONS TO 9 v. CONSOLIDATE; AND GRANTING RETIREMENT SYSTEMS’ MOTIONS 10 FIBROGEN, INC., et al., FOR APPOINTMENT AS LEAD PLAINTIFF AND APPROVAL OF 11 Defendants. LEAD COUNSEL 12 Docket Nos. 22, 29, 40 13 14 I. INTRODUCTION 15 This case is a securities-fraud class action brought on behalf of investors who purchased 16 stock in FibroGen, Inc., from October 2017 through April 2021. Plaintiffs assert claims under 17 Sections 10(b) and 20(a) of the Securities…
2Cases cited7 opinions
- Dura Pharmaceuticals, Inc. v. BroudoSupreme Court of the United States · 2005
- In Re Olsten Corp. Securities Litig.District Court, E.D. New York · 1998
- In Re Network Associates, Inc., Securities LitigationDistrict Court, N.D. California · 1999
- MEDICAL MUTUAL LIABILITY INS. SOC. OF MARYLAND v. EvansCourt of Appeals of Maryland · 1993
- Primavera Familienstiftung v. AskinDistrict Court, S.D. New York · 1997
2 more not listed; retrieve them via the Exa API.